ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Triple Negative Breast Cancer

Ovarian Cancer trials near Jacksonville, FL, USA:

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer (PRESERVE-004)

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: ONC-392
Drug: Pembrolizumab

Phase 2

OncoC4

Jacksonville, Florida, United States and 20 other locations

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....

Enrolling
Epithelial Ovarian Cancer
Endometrioid Ovarian Cancer
Drug: Pegfilgrastim (drug)
Drug: TORL-1-23

Phase 2

TORL Biotherapeutics

Jacksonville, Florida, United States and 65 other locations

as "study drug". The study is focused on patients who have advanced ovarian cancer.The aim of the study is to see how safe, tolerab...

Enrolling
Primary Peritoneal Cancer
Fallopian Tube Cancer
Drug: Bevacizumab
Drug: Sarilumab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Jacksonville, Florida, United States and 52 other locations

, which are pieces of a protein known as "folate receptor alpha" (FRalpha), a protein that is found in high levels on ovarian cancer...

Enrolling
Recurrent Ovarian Carcinoma
Recurrent Ovarian Endometrioid Adenocarcinoma
Procedure: Pheresis
Procedure: Magnetic Resonance Imaging

Phase 1, Phase 2

Mayo Clinic
Mayo Clinic

Jacksonville, Florida, United States and 2 other locations

Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...

Active, not recruiting
Ovarian Neoplasms
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Drug: Dostarlimab-Placebo
Drug: Standard of care

Phase 3

Tesaro
Tesaro

Jacksonville, Florida, United States and 181 other locations

both good and bad, that the maintenance treatment has women with ovarian cancer. In this study, an investigational medication calle ...

Enrolling
Ovarian Cancer
Drug: Niraparib

Phase 4

University of Miami
University of Miami

Jacksonville, Florida, United States of America and 3 other locations

This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...

Active, not recruiting
Ovarian Neoplasms
Drug: Placebo
Drug: Niraparib

Phase 3

Tesaro
Tesaro

Jacksonville, Florida, United States and 115 other locations

as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...

Active, not recruiting
Peritoneal Cancer
Fallopian Tube Cancer
Drug: Bevacizumab
Drug: Mirvetuximab soravtansine plus Bevacizumab

Phase 3

AbbVie
AbbVie

Jacksonville, Florida, United States and 269 other locations

T cell therapy product genetically engineered to express an HLA-A\*02:01-restricted T cell receptor (TCR), targeting TP53 R175H mutant solid tumors...

Enrolling
Other Solid Tumors
Breast Cancer
Biological: Autologous, engineered T Cells targeting TP53 R175H

Phase 1

AstraZeneca
AstraZeneca

Jacksonville, Florida, United States and 17 other locations

following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...

Active, not recruiting
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Drug: Placebo Oral Tablet
Drug: Nivolumab

Phase 3

pharmaand

Jacksonville, Florida, United States and 237 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems